UPB Competitors & Alternatives
Compare Upstream Bio, Inc. with similar stocks in the same industry
Biotechnology
UPB
Main Stock$6.32
Tradestie Score
50
Market Cap
$1.00B
Revenue Growth
0.8%
Analyst Upside
+505.2%
Top Competitors
225 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
AURA
Aura Biosciences, Inc. Common Stock
|
$7.02
|
$382.04M | - | 51 | Compare |
|
DRTS
Alpha Tau Medical Ltd. Ordinary Shares
|
$9.80
|
$371.64M | - | 53 | Compare |
|
CAPR
Capricor Therapeutics Inc
|
$29.60
|
$357.51M | - | 56 | Compare |
|
CGEM
Cullinan Therapeutics, Inc. Common Stock
|
$17.75
|
$354.45M | - | 60 | Compare |
|
LBRX
LB Pharmaceuticals Inc Common Stock
|
$30.60
|
$353.70M | - | 58 | Compare |
|
PROK
ProKidney Corp. Class A Ordinary Shares
|
$1.80
|
$350.98M | - | 62 | Compare |
|
ALT
Altimmune, Inc. Common Stock
|
$2.91
|
$341.56M | - | 59 | Compare |
|
ANNX
Annexon, Inc. Common Stock
|
$5.28
|
$332.96M | - | 53 | Compare |
|
REPL
Replimune Group, Inc.
|
$11.42
|
$328.62M | - | 63 | Compare |
|
CADL
Candel Therapeutics, Inc. Common Stock
|
$9.08
|
$304.12M | - | 61 | Compare |
More UPB Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2834)
225 stocks in this industry